I’d check whether your current security tools work before buying another one. More tools don’t cause breaches - but missing coverage, poor settings, and unclear ownership can leave patient data and care at risk.
I’d start with 3 checks:
- SIEM: Are the right logs arriving, do detections work, and does someone act on alerts - even after hours?
- Endpoint protection: Are devices actively protected, with tested backup controls for systems that can’t run agents?
- Vulnerability management: Do findings reach named owners, get fixed, and pass a retest?
Then I’d map each tool to its assets, owner, and results, including clinical systems and vendor connections. Overlapping features don’t always mean duplicate protection.
My rule: <u>measure protection, response times, and verified fixes - not purchases or closed tickets.</u> Keep controls that work, test before retiring tools, and buy only for a documented gap your team can support. Risk-tracking software can organize assignments and proof, but technical teams still have to make and test the fixes.
Healthcare Cybersecurity: Prove Protection Before Buying Tools
Cybersecurity Roadmap: Global Healthcare Security Architecture
sbb-itb-535baee
Where Healthcare Security Controls Fail
Duplicate tools can send the same event to several queues while other risks go unmonitored. The problem isn’t tool count. It’s broken handoffs between detection, ownership, and action. Name the owner responsible for acting on each finding. Use the failure modes below to check what each tool proves in practice - not what its contract promises.
| Control | Intended protection | Common failure | Proof of effective operation | Accountable owner |
|---|---|---|---|---|
| SIEM | Centralize telemetry and detect suspicious activity across identity, network, server, cloud, and clinical systems | Missing logs, duplicate alerts, untested rules, or inconsistent parsing | Verified log coverage, tested detections, acknowledged alerts, and completed escalations | Security operations lead; CISO accountable |
| Endpoint protection | Detect and prevent malicious activity on workstations, servers, medical devices, and virtual workloads | Inactive agents, broad exclusions, unsupported devices, or absent coverage | Recent check-ins, prevention-test results, reconciled agent-to-asset inventory, and verified compensating controls | Endpoint engineering or infrastructure operations |
| Vulnerability management | Identify exploitable weaknesses and drive risk-based remediation | Findings lack owners, deadlines, or closure checks | Risk-based tickets, rescans, or equivalent validation confirming fixes | Vulnerability-management lead; asset owners execute fixes |
SIEM Logs Without Detection or Escalation
Missing identity, VPN, firewall, EHR, cloud, or vendor logs can derail an investigation. Inconsistent timestamps and fields prevent teams from connecting events, while short retention periods can erase evidence before anyone needs it.
Test detection rules with controlled remote-access scenarios and group duplicate alerts. Assign an on-call owner, an acknowledgment target, a response-time objective, and an after-hours escalation path. Record whether someone investigated each high-priority alert. NIST guidance calls for continuous monitoring, reporting, and escalation when incidents need a higher level of response.[5][6]
Hypothetical community hospital example: A 150-bed hospital forwards VPN, firewall, and identity logs to its SIEM. The system records a contractor account logging in from an unusual location at 2:13 a.m., accessing a remote-management server, and attempting connections to a medication-administration network. The SIEM generates three alerts, but the same events are duplicated by the VPN and endpoint platforms and reduced to a low-priority queue. No team owns after-hours review, the contractor’s manager assumes information technology is investigating, and the security analyst assumes the managed service provider is responsible. The alert remains unresolved until the next business day.
Installed Endpoint Agents Without Active Protection
An installed agent isn’t proof of active protection. It may be stopped, outdated, set to detection-only, or subject to exclusions. Compare console records against the asset inventory, discovery data, virtualization platforms, and clinical engineering records. Separate actively protected assets from those that are inactive, unsupported, unknown, or covered by exceptions.
For medical devices or legacy systems that can’t safely run agents, test compensating controls. Confirm that segmentation blocks unauthorized connections, vendor access is restricted, and monitoring detects suspicious activity. Check manufacturer support requirements before changing device software.[7][8]
Vulnerability Scans Without Verified Fixes
Check that scan findings reach verified remediation, rather than stopping at a ticket. Prioritize them by clinical criticality, exploitability, Internet exposure, and privilege level - not severity alone. Review exposed services, excessive privileges, weak segmentation, and insecure vendor connections. Some require configuration changes, not patches.
Give each finding a named owner, a deadline, and evidence of closure, such as a clean rescan or validated configuration. Coordinate scanning and changes with clinical engineering. Include manufacturer approval where needed, a maintenance window, a rollback plan, and post-change validation. If a fix must wait, document temporary controls, an exception expiration date, and the person authorized to accept the risk.[7][8][9][10]
Review Existing Capabilities Before Buying More
Once you know where controls fail, review what you already own before approving another purchase. More tools reduce risk only when they improve coverage, response, or remediation.
Map Tools to Assets, Outcomes, and Owners
Build a tool inventory before the next renewal. For each tool, record its deployment status, covered assets, owner, operating team, renewal date, dependencies, integrations, alert destinations, retention rules, and outcome metrics. Note whether it protects ePHI systems, supports patient care, or depends on vendor management. Include known assets, shadow IT, unknown assets, and unmanaged assets. HHS identifies asset inventory as a core healthcare cybersecurity practice.[4]
Map each capability to prevention, detection, containment, remediation, or recovery. The point is to test whether controls work across clinical assets - not just list their features. Set a baseline and target for measures such as the percentage of critical assets protected, high-risk findings remediated within an approved time frame, or median time from alert to containment.
Measure SIEMs by detection quality and response, not log volume. HHS guidance treats centralized logging, detection and response, cybersecurity mitigation, and incident planning as separate capabilities, not interchangeable products.[4][11]
Feature overlap does not equal duplicate protection. Compare actual asset coverage and performance rather than marketing labels.
Two scanners may look similar yet one may cover cloud workloads while another assesses medical devices or authenticated configuration weaknesses. Similarly, two endpoint products may differ if one supports behavioral detection and isolation while another supplies specialized controls for servers or devices that cannot run a conventional agent.
Keep deliberate overlap when it protects high-consequence clinical systems or guards against a single control failure. Then compare your inventory with the exposure across clinical systems and vendors.
Find Coverage Gaps Across Clinical Systems and Vendors
Create a coverage matrix by asset class and risk. Include EHR systems, medical devices, lab and imaging systems, pharmacy systems, cloud workloads, remote access, privileged accounts, workstations, servers, and third-party services and their dependencies. For each category, record whether assets are inventoried, covered, and included in response testing.
Pay close attention to unmanaged devices, legacy systems that cannot run agents, vendor-owned platforms, remote maintenance accounts, and cloud services with incomplete logging. HHS and 405(d) guidance emphasize keeping medical-device inventories current, including technical identifiers and network information. They also call for bringing medical-device vulnerability disclosures into vulnerability management.[4][12]
A connector alone does not prove an integration works. Check whether tools share usable asset identifiers, severity definitions, ownership records, tickets, and escalation workflows. Trace a finding from discovery through assignment, action, verification, and closure. If it cannot reach the responsible application owner, that is an integration gap - not necessarily a reason to buy another tool. Use these gaps to decide what to keep, buy, or retire.
Set Criteria for Keeping, Buying, or Retiring Tools
Keep what improves measured protection; retire what duplicates coverage without improving outcomes. Retain separate, tested controls and repair broken workflows. Every purchase should name the unmet risk, affected assets, expected outcome, implementation owner, staffing needs, integration plan, and go-live or retirement criteria.
Before retiring a tool, confirm that the remaining controls preserve detection, response, required evidence retention, and patient-care availability. Run parallel monitoring and test failure and escalation scenarios. Include clinical engineering and vendor representatives before removing device-related controls. Treat decommissioning as an asset-management change, not just a license cancellation.[7][8][13]
Use the inventory to track coverage, response, and remediation.
Measure Coverage, Response, and Remediation
Once you’ve mapped tools to assets and owners, check whether those controls work.
Set a baseline date, then track whether controls reduce risk for the assets that matter most. Review performance trends monthly and control effectiveness quarterly. Record scope changes so new assets don’t distort trends. Measure verified coverage, response, and fixes - not licenses or alert counts.[14][16]
| Activity measure | Proof of effectiveness |
|---|---|
| Security licenses purchased | Critical assets actively protected and correctly configured |
| Endpoint agents installed | In-scope endpoints healthy, updated, and passing tests |
| SIEM alerts generated | Required logs delivered on time, detections tested, and triage measured |
| Vulnerability scans completed | Required assets assessed; critical findings fixed and verified by retest |
| Remediation tickets closed | Findings backed by technical proof or an approved, time-limited exception |
Verify Asset Protection and Log Coverage
On a set schedule, reconcile the authoritative asset inventory with endpoint, SIEM, vulnerability-scanner, network, cloud, and vendor records.
For every metric, define the numerator, denominator, measurement period, exceptions, evidence source, and owner. Use all in-scope critical assets as the denominator, not just assets with deployed agents. Report approved compensating controls separately.
For log coverage, divide the number of required sources sending complete, usable events within the defined delivery window by the total number of required sources. Name the owners responsible for reconciliation, log quality, and exception approval.
Track Response Times and Unresolved Risks
Track median and 90th percentile times for detection, triage, containment, and recovery. Define each measurement’s start and stop points.[15][17] Separate results by severity and clinical impact.
Pair those times with duplicate-alert rates, false positives, and analyst hours spent on correlation. Faster handling of routine alerts can hide slower handling of threats to patient care.
For critical findings, including third-party vendor risks, report the count, median age, oldest item, overdue share, and reopened findings. Track how many have an owner, a due date, a verified fix, or an approved exception with an expiration date.
A closed ticket is not a verified fix: require a rescan or equivalent technical evidence. HHS guidance specifically encourages rescanning and tracking vulnerabilities through closure and reopening.[18]
Use the worst-performing metrics to decide what to retest next.
Test Controls Together
Run exercises with clinical, infrastructure, security, and vendor teams. Test prevention, detection, escalation, segmentation, downtime operations, vendor notification, and restoration from verified backups.
Record actual times, missing logs or telemetry, failed steps, corrective-action owners, and due dates. Then retest. Compare results with the baseline using the same scope and timing definitions.[14][16]
Use the results to reset priorities, and retest after changes. Keep scope and timing definitions consistent for the next measurement cycle.
Conclusion: Coordinate Controls Before Adding Tools
Before adding tools, address gaps in visibility, configuration, integration, coverage, and accountability. Measure progress through tested protection, faster response, and fewer open critical exposures - not tool count. For SIEM, endpoint, and vulnerability tools, prove that controls work and gaps are closed before buying another product.
Set the Order for Risk Reduction
Start by identifying and classifying assets and their dependencies. Then rank exposures by their effect on patient safety, care delivery, PHI, and critical operations.
Assign accountable owners, set remediation deadlines and escalation paths, and require approval for time-limited exceptions. Test the results rather than relying on completion records. HHS’s Healthcare and Public Health Cybersecurity Performance Goals support this focus on high-impact safeguards. They are voluntary guidance, not a substitute for HIPAA or other legal obligations.[2][4]
Apply the same standard to SIEM, endpoint, and vulnerability tools: active coverage, named owners, and verified closure.
Evaluate new products only after reviewing existing controls and workflows. Approve a purchase only if a documented gap remains and the organization has a specific coverage need, clear success measures, and enough staff capacity to run the tool.
Coordinate Risk Tasks With Censinet RiskOps™
Censinet RiskOps™ supports risk documentation, remediation assignments, evidence collection, and tracking of open exposures. Use these workflows to assign findings, attach evidence, and move issues toward closure - not just mark tasks complete. The platform supports accountable action; technical teams still must implement and validate controls.
FAQs
How can we safely test security controls during patient care?
Prioritize clinical impact over technical severity. Before deploying containment tools, have clinical leadership review and approve every automated playbook. Each playbook should spell out when intervention is safe and when it could put patient outcomes at risk.
Go beyond vulnerability scanning with scenario-based tabletop exercises that bring security, IT, and clinical teams together. Use these simulations to test response playbooks and confirm that manual or paper-based care procedures are clearly defined if a system must be isolated.
How should we divide alert ownership with vendors?
Use a RACI model to define who is responsible and accountable across the steering committee and operations teams. Assign roles for alert triage, incident response playbooks, rule creation, containment approvals, and clinical communication [1].
When a vendor controls remediation, make vendor management teams responsible for tracking high-severity findings [2]. Clear ownership helps keep incident oversight from becoming fragmented [1][2].
Which security gaps should we fix first on a limited budget?
Start with gaps that put daily operations, patient safety, and revenue at risk. Rank them by criticality: address Tier 0 (identity infrastructure) first, followed by Tier 1 (EHR, PACS, and medication platforms) [1].
Choose your primary tool based on your most urgent need: EDR for fast endpoint ransomware containment, or SIEM for cross-system visibility and compliance audit logging [2]. Address supply chain and asset management gaps early to reduce blind spots [3][1].
